Promotions and hires for September 26, 2008:

• Merck named Barry J. Goldstein, M.D., vice president of clinical development for diabetes and obesity

• Sanofi-Aventis announced that Chris Viehbacher will succeed current CEO Gerard Le Fur in December

• GlaxoSmithKline named Ellen Strahlman chief medical officer

• Questcor Pharmaceuticals appointed Gary Sawka CFO

• Encorium appointed David Ginsberg president and CEO

• Wyeth named Daniel J. McIntyre vice president, corporate communications

• Genesis Pharmaceuticals appointed John Yang Wang to its board of directors

• Zosano Pharma appointed Gail Schulze chair and CEO

• Lilly named John Lechleiter its board of directors chairman

• Merz Pharmaceuticals named Jack Britts president and CEO

• Ferring Pharmaceuticals appointed Paul Korner, M.D., vice president, medical affairs

• Zafgen appointed Thomas Hughes the company’s first CEO

Tags: announcements, business, communications, Encorium, executives, Ferring, Genesis, GlaxoSmithKline, Lilly, Merck, Merz, new hires, pharmaceutical industry, promotions, Questcor, Sanofi-Aventis, Wyeth, Zafgen, Zosano

This entry was posted on Friday, September 26th, 2008 at 9:53 am and is filed under People. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.